India's Poly Medicure Setting Up 2 Plants as Demand Rise: MD

The company adapted to pandemic challenges by innovating new products like test kits and face masks. They saw growth in international demand, especially in the renal space, and are investing in new manufacturing plants. The focus is on infection prevention products, with plans to expand both domestically and internationally. Vaccination efforts are underway, and the company is optimistic about future demand. However, regulatory challenges in global markets pose a bottleneck.

How did the company adapt to the pandemic to stay in business?

• By innovating new products like test kits and face masks

• By focusing solely on international markets

• By reducing workforce

• By closing down operations temporarily

What was the company's strategy regarding the renal field during the pandemic?

• They expanded into the renal field due to increased demand

• They increased reuse of renal products

• They stopped production of renal products

• They reduced production

What significant change occurred in hospitals as the focus shifted to vaccination?

• Hospitals increased staff

• Hospitals returned to pre-COVID levels

• Hospitals remained closed

• Hospitals reduced elective surgeries

Where did the company expand its facilities in India?

• Mumbai and Delhi

• Jaipur and Friedeberg

• Bangalore and Chennai

• Hyderabad and Pune

What is the company's focus in terms of infection prevention?

• Stopping production of infection control products

• Increasing reuse of medical devices

• Focusing on infection prevention products

• Reducing production of safety devices

What is a major bottleneck the company faces in future growth?

• High employee turnover

• Regulatory challenges in registering new products

• Shortage of raw materials

• Lack of demand

What percentage of the company's revenue comes from the European Union?

• 40%

• 30%

• 20%

• 10%